- Home
- Publications
- Publication Search
- Publication Details
Title
HPV vaccines: alternative dosage schedules
Authors
Keywords
-
Journal
Expert Review of Vaccines
Volume 18, Issue 12, Pages 1309-1316
Publisher
Informa UK Limited
Online
2019-12-18
DOI
10.1080/14760584.2019.1704261
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Dose-related effectiveness of quadrivalent human papillomavirus vaccine against cervical intraepithelial neoplasia: A Danish nationwide cohort study
- (2019) Freija Verdoodt et al. CLINICAL INFECTIOUS DISEASES
- Prevalence of cervical disease at age 20 after immunisation with bivalent HPV vaccine at age 12-13 in Scotland: retrospective population study
- (2019) Tim Palmer et al. BMJ-British Medical Journal
- A mixed two-dose vaccination schedule: Not enough evidence to support a policy change in Quebec
- (2019) Zeev Rosberger et al. VACCINE
- Very Low Prevalence of Vaccine Human Papillomavirus Types Among 18- to 35-Year Old Australian Women 9 Years Following Implementation of Vaccination
- (2018) Dorothy A Machalek et al. JOURNAL OF INFECTIOUS DISEASES
- Early use of the HPV 2-dose vaccination schedule: Leveraging evidence to support policy for accelerated impact
- (2018) Vladimir Gilca et al. VACCINE
- Can a single dose of human papillomavirus (HPV) vaccine prevent cervical cancer? Early findings from an Indian study
- (2018) Rengaswamy Sankaranarayanan et al. VACCINE
- Evidence for single-dose protection by the bivalent HPV vaccine—Review of the Costa Rica HPV vaccine trial and future research studies
- (2018) Aimée R. Kreimer et al. VACCINE
- Human papillomavirus vaccine effectiveness by number of doses: Systematic review of data from national immunization programs
- (2018) Lauri E. Markowitz et al. VACCINE
- Immunogenicity and safety of a mixed vaccination schedule with one dose of nonavalent and one dose of bivalent HPV vaccine versus two doses of nonavalent vaccine – A randomized clinical trial
- (2018) Vladimir Gilca et al. VACCINE
- The investment case for cervical cancer elimination
- (2017) Vivien Davis Tsu et al. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
- Immunogenicity of 2 vs 3 Doses of the Quadrivalent Human Papillomavirus Vaccine in Girls Aged 9 to 13 Years After 60 Months
- (2017) Gina Ogilvie et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Analysis of Memory B-Cell Responses Reveals Suboptimal Dosing Schedule of a Licensed Vaccine
- (2017) Erin M Scherer et al. JOURNAL OF INFECTIOUS DISEASES
- Durability of Protection Afforded by Fewer Doses of the HPV16/18 Vaccine: The CVT Trial
- (2017) Mahboobeh Safaeian et al. JNCI-Journal of the National Cancer Institute
- Changes in the prevalence of human papillomavirus following a national bivalent human papillomavirus vaccination programme in Scotland: a 7-year cross-sectional study
- (2017) Kimberley Kavanagh et al. LANCET INFECTIOUS DISEASES
- Durability of Protection Afforded by Fewer Doses of the HPV16/18 Vaccine: The CVT Trial
- (2017) Mahboobeh Safaeian et al. JNCI-Journal of the National Cancer Institute
- Impact and Effectiveness of the Quadrivalent Human Papillomavirus Vaccine: A Systematic Review of 10 Years of Real-world Experience
- (2016) Suzanne M. Garland et al. CLINICAL INFECTIOUS DISEASES
- Immunogenicity and HPV infection after one, two, and three doses of quadrivalent HPV vaccine in girls in India: a multicentre prospective cohort study
- (2016) Rengaswamy Sankaranarayanan et al. LANCET ONCOLOGY
- Global estimates of human papillomavirus vaccination coverage by region and income level: a pooled analysis
- (2016) Laia Bruni et al. Lancet Global Health
- Dose-Related Differences in Effectiveness of Human Papillomavirus Vaccination Against Genital Warts: A Nationwide Study of 550 000 Young Girls
- (2015) Maria Blomberg et al. CLINICAL INFECTIOUS DISEASES
- Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis
- (2015) Mélanie Drolet et al. LANCET INFECTIOUS DISEASES
- Evaluation of the immunogenicity of the quadrivalent HPV vaccine using 2 versus 3 doses at month 21: An epidemiological surveillance mechanism for alternate vaccination schemes
- (2015) Mauricio Hernández-Ávila et al. Human Vaccines & Immunotherapeutics
- Persistent infection with human papillomavirus 16 or 18 is strongly linked with high-grade cervical disease
- (2015) David Radley et al. Human Vaccines & Immunotherapeutics
- Sustained immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine administered as a two-dose schedule in adolescent girls: Five-year clinical data and modeling predictions from a randomized study
- (2015) Barbara Romanowski et al. Human Vaccines & Immunotherapeutics
- Evaluating the Early Benefit of Quadrivalent HPV Vaccine on Genital Warts in Belgium: A Cohort Study
- (2015) Geraldine Dominiak-Felden et al. PLoS One
- Association of Varying Number of Doses of Quadrivalent Human Papillomavirus Vaccine With Incidence of Condyloma
- (2014) Eva Herweijer et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Raising Expectations For Subunit Vaccine
- (2014) John T. Schiller et al. JOURNAL OF INFECTIOUS DISEASES
- Effectiveness of quadrivalent human papillomavirus vaccine for the prevention of cervical abnormalities: case-control study nested within a population based screening programme in Australia
- (2014) E. Crowe et al. BMJ-British Medical Journal
- Immunogenicity of quadrivalent HPV and combined hepatitis A and B vaccine when co-administered or administered one month apart to 9–10 year-old girls according to 0–6 month schedule
- (2014) Vladimir Gilca et al. Human Vaccines & Immunotherapeutics
- Immunogenicity of 2 Doses of HPV Vaccine in Younger Adolescents vs 3 Doses in Young Women
- (2013) Simon R. M. Dobson et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Overcoming barriers to HPV vaccination: Non-inferiority of antibody response to human papillomavirus 16/18 vaccine in adolescents vaccinated with a two-dose vs. a three-dose schedule at 21 months
- (2013) Eduardo Lazcano-Ponce et al. VACCINE
- Genital warts in young Australians five years into national human papillomavirus vaccination programme: national surveillance data
- (2013) H. Ali et al. BMJ-British Medical Journal
- Global Burden of Human Papillomavirus and Related Diseases
- (2012) David Forman et al. VACCINE
- A Review of Clinical Trials of Human Papillomavirus Prophylactic Vaccines
- (2012) John T. Schiller et al. VACCINE
- Immunogenicity and safety of the HPV-16/18 AS04-adjuvanted vaccine administered as a 2-dose schedule compared to the licensed 3-dose schedule
- (2011) Barbara Romanowski et al. Human vaccines & immunotherapeutics
- Natural History of Genital Warts: Analysis of the Placebo Arm of 2 Randomized Phase III Trials of a Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) Vaccine
- (2009) Suzanne M. Garland et al. JOURNAL OF INFECTIOUS DISEASES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started